We show that transgenic as well as chemical suppression of AP nucleases inhibits RAD51 expression in MM as well as esophageal cancer (not shown) cells, whereas transgenic upregulation of APEX1 as well as APEX2 induces RAD51 expression. The gene discussed is APEX1; the disease is Miyoshi myopathy.